You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (71)

Journals (0)

1-10 of 71 results for TKI toxicities

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds

Open access

Review article

First published 2015

More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds

Maria Vergoulidou

Biomarker Insights

Select article: Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in EGFR Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center,Prospective,Double-Blinded,Randomized-Controlled Pilot Trial

Open access

Research article

First published 2022

Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in EGFR Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center,Prospective,Double-Blinded,Randomized-Controlled Pilot Trial

Chia-Ling Li, Te-Chun Hsia, Su-Tso Yang [...]

Integrative Cancer Therapies

Select article: EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC

Retricted access

Review article

First published 2012-6

EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC

Kimberly J Gorden, Parvin Mesbah, Jill M Kolesar

Journal of Oncology Pharmacy Practice

Select article: Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review

Retricted access

Review article

First published 2023

Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review

Seyyed Javad Boskabadi, Ayat Dashti, Sara Karevan [...]

Journal of Oncology Pharmacy Practice

Select article: Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential

Open access

Review article

First published 2017-10

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential

Melissa Bersanelli, Sebastiano Buti

Therapeutic Advances in Medical Oncology

Select article: Management and Mechanisms of Diarrhea Induced by Tyrosine Kinase Inhibitors in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

Open access

Research article

First published 2024-08

Management and Mechanisms of Diarrhea Induced by Tyrosine Kinase Inhibitors in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

Kena Sun, Xiaojia Wang, Huanping Zhang [...]

Cancer Control

Select article: Metabolic complete tumor response in a patient with epidermal growth factor receptor mutant non-small cell lung cancer treated with a reduced dose of afatinib

Open access

Case report

First published 2022-3

Metabolic complete tumor response in a patient with epidermal growth factor receptor mutant non-small cell lung cancer treated with a reduced dose of afatinib

Ivana Puliafito, Francesca Esposito, Gabriele Raciti [...]

Journal of International Medical Research

Select article: Transformation to Small Cell Lung Cancer as an Acquired Resistance Mechanism in EGFR -mutant Lung Adenocarcinoma: A Case Report of Complete Response to Etoposide and Cisplatin

Retricted access

Case report

First published 2015-5

Transformation to Small Cell Lung Cancer as an Acquired Resistance Mechanism in EGFR -mutant Lung Adenocarcinoma: A Case Report of Complete Response to Etoposide and Cisplatin

Ki-Eun Hwang, Jae-Wan Jung, Su-Jin Oh [...]

Tumori Journal

Select article: Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

Open access

Research article

First published 2024

Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

Judith Gulikers, Jeroen Bruinsma, Janna Schoenmaekers [...]

Therapeutic Advances in Medical Oncology

Select article: Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient

Retricted access

Other

First published 2011-9

Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient

Umut Demirci, Ugur Coskun, Ozlem Erdem [...]

Journal of Oncology Pharmacy Practice

1
2
3
•••
8
10 / page

Article type

Publication date

Subjects

Access